AAAAAA
Results:
1-20
|
Results: 20
Immunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model
Authors:
Puurunen, M
Palosuo, T
Lassila, R
Anttila, M
Vaarala, O
Citation: M. Puurunen et al., Immunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model, LUPUS, 10(2), 2001, pp. 108-115
Authors:
Laine, K
Anttila, M
Nyman, L
Wahlberg, A
Bertilsson, L
Citation: K. Laine et al., CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline, EUR J CL PH, 57(2), 2001, pp. 137-142
Authors:
Kivisto, KT
Wang, JS
Backman, JT
Nyman, L
Taavitsainen, P
Anttila, M
Neuvonen, PJ
Citation: Kt. Kivisto et al., Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole, EUR J CL PH, 57(1), 2001, pp. 37-42
Authors:
Taavitsainen, P
Anttila, M
Nyman, L
Karnani, H
Salonen, JS
Pelkonen, O
Citation: P. Taavitsainen et al., Selegiline metabolism and cytochrome P450 enzymes: In vitro study in humanliver microsomes, PHARM TOX, 86(5), 2000, pp. 215-221
Authors:
Vaarasmaki, MS
Hartikainen, AL
Anttila, M
Pramila, S
Koivisto, M
Citation: Ms. Vaarasmaki et al., Factors predicting peri- and neonatal outcome in diabetic pregnancy, EAR HUM DEV, 59(1), 2000, pp. 61-70
Authors:
Laine, K
Anttila, M
Huupponen, R
Maki-Ikola, O
Heinonen, E
Citation: K. Laine et al., Multiple-dose pharmacokinetics of selegiline and desmethylselegiline suggest saturable tissue binding, CLIN NEUROP, 23(1), 2000, pp. 22-27
Authors:
Braybrooke, JP
Vallis, KA
Houlbrook, S
Rockett, H
Ellmen, J
Anttila, M
Ganesan, TS
Harris, AL
Talbot, DC
Citation: Jp. Braybrooke et al., Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine, CANC CHEMOT, 46(1), 2000, pp. 27-34
Authors:
Penttila, T
Vuola, JM
Puurula, V
Anttila, M
Sarvas, M
Rautonen, N
Makela, PH
Puolakkainen, M
Citation: T. Penttila et al., Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2), VACCINE, 19(9-10), 2000, pp. 1256-1265
Authors:
Vaarasmaki, M
Hartikainen, AL
Anttila, M
Pirttiaho, H
Citation: M. Vaarasmaki et al., Out-patient management does not impair outcome of pregnancy in women with type 1 diabetes, DIABET RE C, 47(2), 2000, pp. 111-117
Authors:
Launonen, V
Mannermaa, A
Stenback, F
Kosma, VM
Puistola, U
Huusko, P
Anttila, M
Bloigu, R
Saarikoski, S
Kauppila, A
Winqvist, R
Citation: V. Launonen et al., Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables, CANC GENET, 122(1), 2000, pp. 49-54
Authors:
Kuusela, E
Raekallio, M
Anttila, M
Falck, I
Molsa, S
Vainio, O
Citation: E. Kuusela et al., Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs, J VET PHARM, 23(1), 2000, pp. 15-20
Authors:
Saari, S
Rasi, J
Anttila, M
Citation: S. Saari et al., Leishmaniosis mimicking oral neoplasm in a dog: An unusual manifestation of an unusual disease in Finland, ACT VET SC, 41(1), 2000, pp. 101-104
Authors:
Vuola, JM
Puurula, V
Anttila, M
Makela, PH
Rautonen, N
Citation: Jm. Vuola et al., Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferonin two mouse strains that initially differ in this respect after primary challenge, INFEC IMMUN, 68(2), 2000, pp. 960-964
Authors:
Eskola, J
Anttila, M
Citation: J. Eskola et M. Anttila, Pneumococcal conjugate vaccines, PEDIAT INF, 18(6), 1999, pp. 543-551
Authors:
Laine, K
Anttila, M
Helminen, A
Karnani, H
Huupponen, R
Citation: K. Laine et al., Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids, BR J CL PH, 47(3), 1999, pp. 249-254
Authors:
Anttila, M
Eskola, J
Ahman, H
Kayhty, H
Citation: M. Anttila et al., Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood, VACCINE, 17(15-16), 1999, pp. 1970-1977
Authors:
Anttila, M
Syrjanen, S
Ji, H
Saarikoski, S
Syrjanen, K
Citation: M. Anttila et al., Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR, GYNECOL ONC, 72(3), 1999, pp. 337-341
Authors:
Pentilla, JM
Anttila, M
Varkila, K
Poulakkainen, M
Sarvas, M
Makela, PH
Rautonen, N
Citation: Jm. Pentilla et al., Depletion of CD8(+) cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice, IMMUNOLOGY, 97(3), 1999, pp. 490-496
Authors:
Anttila, M
Voutilainen, M
Jantti, V
Eskola, J
Kayhty, H
Citation: M. Anttila et al., Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae, CLIN EXP IM, 118(3), 1999, pp. 402-407
Authors:
Kivisto, KT
Villikka, K
Nyman, L
Anttila, M
Neuvonen, PJ
Citation: Kt. Kivisto et al., Tamoxifen and toremifene concentrations in plasma are greatly decreased byrifampin, CLIN PHARM, 64(6), 1998, pp. 648-654
Risultati:
1-20
|